About NewBiologix
Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies.
Headquarters
Epalinges, SwitzerlandWebsite
https://www.newbiologix.com/Company Size
11-50 employeesIndustry
Biotechnology ResearchCompany Type
Privately HeldFounded
2023Specialties
gene therapy, cell therapy, next-generation sequencing, NGS, rAAV, viral vectors, biologics, stable cell lines, Genomic Integration, stem cell, bioinformatics, capsid optimization, HEK293, gene expression, ATMPs, genomic, epigenetic, transcriptomic, mammalian cell lines, and human cell lines